fda glp-1 news november 2025 The medical cycle was anything but quiet. ⬇️ The Trump administration's significant changes to U.S. healthcare policy dominated headlines in 2025 and comprised many of MedPage Today's most-read stories. In Medicare will negotiate Novo's GLP-1

Retatrutide includes GLP-1 receptor activation as one of its three mechanisms

Interestingly, participants receiving GLP-1 RA therapy demonstrated an increase in weight compared with the SGLT2i group

#AscendisPharma #NovoNordisk #TransConTechnology #MetabolicDiseases #CardiovascularDiseases #Biopharma #HealthcareInnovation #GLP1 To view or add a comment, sign in More Relevant Posts Breaking News: Novo Nordisk Wins FDA Approval for #Oral #Heart #Drug #Rybelsus A new milestone for cardiometabolic care the U.S

The Three-Factor Eating Questionnaire, body mass index, and responses to sweet and salty fatty foods: a twin study of genetic and environmental associations

With injectible GLP-1s, local reactions like itchiness or redness may occur at the injection site

What happens if your BMI falls below 27 This is the question that generates the most debate